Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jennie Gustafsson Insider Profile
4 Followers
Jennie Gustafsson, Senior Officer, Ten Percent Owner at Diamedica Therapeutics, holds 8.04M shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, Jennie Gustafsson ― shares of Diamedica Therapeutics on ― for an estimated value of ―.
Jennie Gustafsson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jennie Gustafsson's holdings
Insider Roles
Senior Officer, Ten Percent Owner
Roles that Jennie Gustafsson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jennie Gustafsson
Jennie Gustafsson's Trading History
List of latest transactions for each holding click on a transaction to see Jennie Gustafsson's performance on stock
You May Also Like
Jennie Gustafsson insider profile FAQ
What is the percentage of profitable transactions made by Jennie Gustafsson?
The percentage of profitable transactions made by Jennie Gustafsson is ―.
What is the average return per transaction made by Jennie Gustafsson?
The average return per transaction made by Jennie Gustafsson is ―.
What stocks does Jennie Gustafsson hold?
Jennie Gustafsson holds: DMAC stocks.
What was Jennie Gustafsson’s latest transaction?
Jennie Gustafsson latest transaction was an Uninformative Buy of ―.
What was Jennie Gustafsson's most profitable transaction?
Jennie Gustafsson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jennie Gustafsson's role in Diamedica Therapeutics?
Jennie Gustafsson's role in Diamedica Therapeutics is Senior Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.